A phase Ib/II study of non-randomized, open-label, single-arm Phase II, multicenter study in RAS evaluation of the safety of Amelimumab injection combined with FOLFIRI in first-line treatment of patients with wild-type advanced colorectal cancer
Latest Information Update: 26 Jul 2022
At a glance
- Drugs Amelimumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
Most Recent Events
- 26 Jul 2022 New trial record